Log in to save to my catalogue

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe...

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3058638519

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

About this item

Full title

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

Journal title

European heart journal. Case reports, 2024, Vol.8 (5), p.ytae237-ytae237

Language

English

Formats

More information

Scope and Contents

Contents

BackgroundThere is a growing need for percutaneous coronary intervention (PCI) to be performed within the same transcatheter aortic valve implantation (TAVI) procedure. In such cases, cangrelor, a fast-acting intravenous P2Y12-inhibitor with a short offset, is potential clinical utility to minimize bleeding and vascular complications during large-b...

Alternative Titles

Full title

Use of cangrelor for complex percutaneous coronary intervention in the context of concomitant severe aortic stenosis: a case series

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3058638519

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3058638519

Other Identifiers

E-ISSN

2514-2119

DOI

10.1093/ehjcr/ytae237

How to access this item